Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/45834
Title: Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism
Authors: Pérez Alenza, Dolores
Arenas, Carolina
Lopez, Mari Luz
Melián Limiñana, Carlos 
UNESCO Clasification: 310907 Patología
Keywords: Trilostane
Hyperadrenocorticism
Dogs
Issue Date: 2006
Publisher: 1547-3317
Journal: Journal of the American Animal Hospital Association 
Abstract: Trilostane is considered an efficacious and safe medication for canine pituitary-dependent hyperadrenocorticism (PDH). Its recommended frequency of administration is once daily. In this prospective study, the efficacy, toxicity, and long-term outcome of trilostane administered twice daily per os were evaluated in 44 dogs with PDH. Mean initial dose was 3.1 mg/kg q 12 hours, and mean final dose was 3.2 mg/kg q 12 hours. The final total daily dose was lower than previously reported for once-daily administration. The mean survival time for affected dogs was 930 days.
URI: http://hdl.handle.net/10553/45834
ISSN: 1547-3317
DOI: 10.5326/0420269
Source: Journal of the American Animal Hospital Association [ISSN 1547-3317], v. 42, p. 269-276
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

68
checked on Nov 3, 2024

WEB OF SCIENCETM
Citations

58
checked on Nov 3, 2024

Page view(s)

110
checked on Jul 27, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.